These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14592998)

  • 1. Life-threatening thrombosis in mice with targeted Arg48-to-Cys mutation of the heparin-binding domain of antithrombin.
    Dewerchin M; Hérault JP; Wallays G; Petitou M; Schaeffer P; Millet L; Weitz JI; Moons L; Collen D; Carmeliet P; Herbert JM
    Circ Res; 2003 Nov; 93(11):1120-6. PubMed ID: 14592998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser.
    Borg JY; Owen MC; Soria C; Soria J; Caen J; Carrell RW
    J Clin Invest; 1988 Apr; 81(4):1292-6. PubMed ID: 3350974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homozygous antithrombin deficiency: report of two new cases (99 Leu to Phe) associated with arterial and venous thrombosis.
    Chowdhury V; Lane DA; Mille B; Auberger K; Gandenberger-Bachem S; Pabinger I; Olds RJ; Thein SL
    Thromb Haemost; 1994 Aug; 72(2):198-202. PubMed ID: 7831651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report of a novel kindred with antithrombin heparin-binding site variant (47 Arg to His): demand for an automated progressive antithrombin assay to detect molecular variants with low thrombotic risk.
    Rossi E; Chiusolo P; Za T; Marietti S; Ciminello A; Leone G; De Stefano V
    Thromb Haemost; 2007 Sep; 98(3):695-7. PubMed ID: 17849067
    [No Abstract]   [Full Text] [Related]  

  • 5. Introduction of a mutation in the shutter region of antithrombin (Phe77 --> Leu) increases affinity for heparin and decreases thermal stability.
    Quinsey NS; Fitton HL; Coughlin P; Whisstock JC; Dafforn TR; Carrell RW; Bottomley SP; Pike RN
    Biochemistry; 2003 Sep; 42(34):10169-73. PubMed ID: 12939144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of N-terminal region residues Lys11, Arg13, and Arg24 of antithrombin in heparin recognition and in promotion and stabilization of the heparin-induced conformational change.
    Schedin-Weiss S; Desai UR; Bock SC; Olson ST; Björk I
    Biochemistry; 2004 Jan; 43(3):675-83. PubMed ID: 14730971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin is as effective as heparin and hirudin to prevent formation of microvascular thrombosis in a murine model.
    Sorg H; Hoffmann JN; Menger MD; Lindenblatt N; Goehring P; Vollmar B
    Thromb Haemost; 2006 Sep; 96(3):371-7. PubMed ID: 16953281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations.
    Tiede A; Tait RC; Shaffer DW; Baudo F; Boneu B; Dempfle CE; Horellou MH; Klamroth R; Lazarchick J; Mumford AD; Schulman S; Shiach C; Bonfiglio LJ; Frieling JT; Conard J; von Depka M
    Thromb Haemost; 2008 Mar; 99(3):616-22. PubMed ID: 18327412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous variant of antithrombin with lack of affinity for heparin: management of severe thrombotic complications associated with intrauterine fetal demise.
    Bauters A; Zawadzki C; Bura A; Théry C; Watel A; Subtil D; Aiach M; Emmerich J; Jude B
    Blood Coagul Fibrinolysis; 1996 Oct; 7(7):705-10. PubMed ID: 8958394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Type I hereditary antithrombin deficiency due to C2757T heterozygotic mutation in antithrombin gene].
    Zhou RF; Dai Q; Fu QH; Wang WB; Xue S; Ding QL; Hu YQ; Wang XF; Wang HL
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1640-2. PubMed ID: 16185535
    [No Abstract]   [Full Text] [Related]  

  • 11. [Homozygous antithrombin type HBS deficiency; a family study].
    Guermazi S; Elloumi-ZghaL H; Ben Hassine L; Romani S; Khalfallah N; Abdelhak S; Dellagi K
    Pathol Biol (Paris); 2007 Jun; 55(5):256-61. PubMed ID: 17140748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent leg ulcers and arterial thrombosis in a 33-year-old homozygous variant of antithrombin.
    Shimizu K; Toriyama F; Ogawa F; Katayama I; Okajima K
    Am J Hematol; 2001 Apr; 66(4):285-91. PubMed ID: 11279641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleiotropic effects of antithrombin strand 1C substitution mutations.
    Lane DA; Olds RJ; Conard J; Boisclair M; Bock SC; Hultin M; Abildgaard U; Ireland H; Thompson E; Sas G
    J Clin Invest; 1992 Dec; 90(6):2422-33. PubMed ID: 1469094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of antithrombin deficiency in two Chinese families. One novel and one recurrent point mutation in the antithrombin gene causing venous thrombosis.
    Zhou RF; Fu QH; Wang WB; Xie S; Dai J; Ding QL; Wang XF; Wang HL; Wang ZY
    Thromb Haemost; 2005 Dec; 94(6):1172-6. PubMed ID: 16411389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin and heparin.
    Carrell R; Skinner R; Warden M; Whisstock J
    Mol Med Today; 1995 Aug; 1(5):226-31. PubMed ID: 17607884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autoantibodies to heparin polysaccharides bind to vascular endothelial cells].
    Shibata S
    Rinsho Byori; 1998 Dec; 46(12):1205-9. PubMed ID: 9916505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
    Rezaie AR
    Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and characterization of a t-PA mutant for use in ATTEMPTS: a drug delivery system for achieving targeted thrombolysis.
    Yang VC; Naik SS; Song H; Dombkowski AA; Crippen G; Liang JF
    J Control Release; 2005 Dec; 110(1):164-76. PubMed ID: 16260060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of tryptophan 49 of antithrombin in heparin binding and conformational activation.
    Monien BH; Krishnasamy C; Olson ST; Desai UR
    Biochemistry; 2005 Sep; 44(35):11660-8. PubMed ID: 16128566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.